Rapamycin Can Cause Diabetic-Like State

A study published in Cell Metabolism reports that scientists at the Dana-Farber Cancer Institute have discovered why some patients who receive rapamycin, an immuno-suppressant that also has anti-cancer activity, and may even slow ageing, have developed symptoms similar to diabetes. Rapamycin, which is commonly administered to prevent organ rejection, is currently undergoing clinical trials as a cancer treatment...